Have you listened to Paul's comment in the GRAFA interview?
https://grafa.com/news/paradigm-biopharma--asx-par--pursuing-fda-review-247123
Clearest indication yet they're waiting to sign!! (....my comment: Term Sheets may need to be updated once FDA confirms P3 protocol, including timeframes).
It may still NOT happen, however, there is more chance than ever before that it WILL.
Have you listened to Paul's comment in the GRAFA interview?...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $68.29M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.5¢ | $3.676K | 18.71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 197874 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 17429 | 4 |
View Market Depth
| Last trade - 10.35am 02/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |